Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jordan

Showing results (511-520 of 572) with videos related to

Pageof 58
Sort By:
Haematologica|September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosisRui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Pediatric Blood & Cancer|October 2, 2018
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosisArun Gurunathan, Alexander A Boucher, Melissa Mark, et al.
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Molecular Cell|May 5, 2026
CRL2<sup>FEM1B</sup> uses heme to recruit BACH1 for degradation and regulate ferroptosis in lung cancerBashir Ahmed, Daniele Salaun, Jack B Jordan, et al.
Critical Care Medicine|October 4, 2021
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and AdultsMelissa R Hines, Tatiana von Bahr Greenwood, Gernot Beutel, et al.
Breast Cancer Research and Treatment|September 3, 2010
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapyAlastair M Thompson, Andrea Johnson, Philip Quinlan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell TransplantationPooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Blood|November 15, 2021
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosisAdi Zoref-Lorenz, Jun Murakami, Liron Hofstetter, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
The New England Journal of Medicine|May 7, 2020
Emapalumab in Children with Primary Hemophagocytic LymphohistiocytosisFranco Locatelli, Michael B Jordan, Carl Allen, et al.
Pageof 58

Showing results (511-520 of 572) with videos related to

Sort By:
Pageof 58
Haematologica|September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosisRui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Pediatric Blood & Cancer|October 2, 2018
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosisArun Gurunathan, Alexander A Boucher, Melissa Mark, et al.
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Molecular Cell|May 5, 2026
CRL2<sup>FEM1B</sup> uses heme to recruit BACH1 for degradation and regulate ferroptosis in lung cancerBashir Ahmed, Daniele Salaun, Jack B Jordan, et al.
Critical Care Medicine|October 4, 2021
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and AdultsMelissa R Hines, Tatiana von Bahr Greenwood, Gernot Beutel, et al.
Breast Cancer Research and Treatment|September 3, 2010
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapyAlastair M Thompson, Andrea Johnson, Philip Quinlan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell TransplantationPooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Blood|November 15, 2021
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosisAdi Zoref-Lorenz, Jun Murakami, Liron Hofstetter, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
The New England Journal of Medicine|May 7, 2020
Emapalumab in Children with Primary Hemophagocytic LymphohistiocytosisFranco Locatelli, Michael B Jordan, Carl Allen, et al.
Pageof 58